Showing results (1-10 of 247) with videos related to
Sort By:
Pageof 25
BMJ (Clinical Research Ed.)|October 18, 2017
Why and how to step down chronic asthma drugsMichael R Gionfriddo, John B Hagan, Matthew A RankAllergy and Asthma Proceedings|June 25, 2015
Stepping down inhaled corticosteroids from scheduled to as needed in stable asthma: Systematic review and meta-analysisMichael R Gionfriddo, John B Hagan, Christina R Hagan, et al.Current Allergy and Asthma Reports|February 18, 2015
Assessing the risks and benefits of step-down asthma care: a case-based approachJohn B Hagan, Matthew A RankAllergy and Asthma Proceedings|May 16, 2015
Stepping down from inhaled corticosteroids with leukotriene inhibitors in asthma: a systematic review and meta-analysisMatthew A Rank, Michael R Gionfriddo, Thanai Pongdee, et al.American Journal of Rhinology & Allergy|April 9, 2013
A proposed model to study immunologic changes during chronic rhinosinusitis exacerbations: data from a pilot studyMatthew A Rank, John B Hagan, Shefali A Samant, et al.Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 13, 2022
Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal AntibodiesJohn B Hagan, Elizabeth Ender, Rohit D Divekar, et al.Biostatistics (Oxford, England)|November 10, 2017
Prediction of individual outcomes for asthma sufferersCurtis B Storlie, Megan E Branda, Michael R Gionfriddo, et al.Chest|May 22, 2015
Long-term Outcomes After Stepping Down Asthma Controller Medications: A Claims-Based, Time-to-Event AnalysisMatthew A Rank, Ryan Johnson, Megan Branda, et al.The Journal of Allergy and Clinical Immunology|October 28, 2015
Comparative safety and costs of stepping down asthma medications in patients with controlled asthmaMatthew A Rank, Juliette T Liesinger, Megan E Branda, et al.BMC Medicine|October 6, 2018
Balancing feasibility and comprehensiveness: examining medications for reducing emergency hospital admissionsMichael R GionfriddoPageof 25